The infrequency of "pure culture" diagnoses among the anxiety disorders.

Brown University School of Medicine, Department of Psychiatry and Behavioral Sciences, Providence, RI, USA.
The Journal of Clinical Psychiatry (Impact Factor: 5.14). 12/1996; 57(11):528-33. DOI: 10.4088/JCP.v57n1105
Source: PubMed

ABSTRACT Anxiety disorders are known to commonly coexist in individuals, both with other anxiety disorders and with mental disorders from other groupings, such as affective disorders. We questioned how frequently anxiety disorders actually occur in isolation, as "pure cultures."
We examined diagnostic patterns among the 711 subjects entered into a large, multicenter study of anxiety disorders, the Harvard/ Brown Anxiety Disorders Research Program (HARP), which focused on panic, agoraphobia, generalized anxiety disorder, and social phobias as "index disorders" required for intake.
We used various definitions for "pure culture." By all definitions, subjects with "pure culture" represented a minority, especially in cases of generalized anxiety disorder and social phobia, where comorbidity was virtually ubiquitous. "Pure culture" status was associated with later onset of illness and less chronicity.
Future studies of anxiety disorder should aim to document the extensive comorbidity, rather than eliminate it by restrictive diagnostic exclusion criteria, lest they yield atypical or even misrepresented groups of patients. Clinicians should not stop at identifying only the "main" diagnosis but look for other, comorbid diagnoses that are often present.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Concurrent panic disorder with agoraphobia (PDA) and generalized anxiety disorder (GAD) are the most common diagnostic occurrences among anxiety disorders. This particular comorbidity is associated with significant impairments in quality of life (QOL). The current study sought to investigate the efficacy of a combined cognitive-behavioral psychotherapy that addressed both conditions compared with a conventional psychotherapy, which attends solely to the primary disorder. The hypotheses postulated firstly, that both treatment conditions would lead to improvements in participants' QOL and secondly, that the combined therapy would lead to greater QOL ameliorations. Twenty-five participants with comorbid PDA/GAD diagnoses were evaluated with a number of clinical interviews and self-report questionnaires, and were provided with either conventional or combined cognitive-behavioral psychotherapy, which consisted of 14 one-hour weekly sessions. Participants were once again evaluated in the same fashion 2-weeks after the completion of the psychotherapy. The results revealed that both conditions led to significant improvements in participants' QOL, but that the two groups did not significantly differ in terms of the effect on QOL. The results also reveal that the two conditions did not significantly differ in terms of their effect on PDA and GAD symptomatology or psychiatric comorbidity. The results demonstrate that the combined psychotherapy, which addresses both conditions simultaneously, is similar to the conventional psychotherapy employed for the primary disorder in terms of QOL enhancement, symptom severity, and comorbidity reduction.
    Behavior modification 09/2013; 38(1). DOI:10.1177/0145445513504430 · 2.23 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objective: To validate the Penn State Worry Questionnaire for the detection of Generalized Anxiety Disorder. Method: 100 outpatients from the Psychiatry Department of the Hospital Vargas de Caracas were evaluated. After completing the Penn State Worry Questionnaire, they were assessed with the Structured Clinical Interview for DSM-IV for Axis I Disorders (SCID-I). The Fisher Exact Test (two-tailed) was used for statistical analysis with a P > 0.05. Results: The Penn State Worry Questionnaire showed 76.9 % of sensitivity and 66.6 % of specificity for the diagnosis of Generalized Anxiety Disorder. The Generalized Anxiety Disorder prevalence according to the SCID was 13 %. Almost half of the patients presented comorbidity, especially with Major Depression. Generalized Anxiety Disorder was more frequent in women over 30 years old. Conclusions: The Penn State Worry Questionnaire is a valid questionnaire to diagnose Generalized Anxiety Disorder in psychiatric outpatients, however, patients had difficulties to answer it.
    06/2007; 30(1):38-42.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The present study sought to quantify the generalizability of clinical trial results in individuals with a Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) diagnosis of borderline personality disorder (BPD) to a large representative community sample. Data were derived from the 2004-2005 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC), a large nationally representative sample of 34,653 adults from the United States population. We applied a standard set of exclusion criteria representative of pharmacological and psychotherapy clinical trials to all adults with a DSM-IV diagnosis of BPD (n = 2,231). Our aim was to assess how many participants with BPD would not fulfill typical eligibility criteria. We found that more than 7 of 10 respondents in a typical pharmacological efficacy trial and more than 5 of 10 participants in a typical psychotherapy efficacy trial would have been excluded by at least 1 criterion. Having a current history of alcohol or drug use disorder and a lifetime history of bipolar disorder explained a large proportion of ineligibility in both pharmacological and psychotherapy efficacy trials. Clinical trials should carefully consider the impact of exclusion criteria on the generalizability of their results. As required by CONSORT guidelines, reporting exclusion rate estimate and reasons of eligibility should be mandatory in both clinical trials and meta-analyses. As treatment trials of borderline personality disorder move from efficacy to effectiveness to better inform clinical practice, the eligibility rate must be increased by imposing less stringent eligibility criteria to allow for more generalizable results. (PsycINFO Database Record (c) 2015 APA, all rights reserved).
    Personality Disorders: Theory, Research, and Treatment 01/2015; 6(1):81-7. DOI:10.1037/per0000091 · 3.54 Impact Factor


Available from
May 19, 2014